Announcements Trials
Browse Landscape

Status

Recruiting 8Active not recruiting 6Not yet recruiting 5Completed 5Terminated 3Unknown 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Observational 3

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 4Thoracic 3Breast 3Sarcoma 2Gynecologic 2Other neoplasm 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1Head & Neck 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Pneumonia 1Lung Diseases, Interstitial 1

Interventions

Carboplatin 158Pemetrexed 135Cisplatin 115pembrolizumab 98Docetaxel 94Paclitaxel 89Gemcitabine 63Erlotinib Hydrochloride 60Radiotherapy 55Nivolumab 55Bevacizumab 46Etoposide 42atezolizumab 33Radiosurgery 33durvalumab 27Cyclophosphamide 22Vinorelbine 21Ipilimumab 21Radiation 20Taxes 17130-nm albumin-bound paclitaxel 17Albumin-Bound Paclitaxel 16Gefitinib 14Irinotecan 13Drug Therapy 13osimertinib 12avelumab 12Magnetic Resonance Spectroscopy 12Dexamethasone 12Vorinostat 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Observation × Thoracic × Clear all
NCT06192004 2026-05-04

LOOP

AstraZeneca

Terminated
83 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pneumonia, Lung Diseases, Interstitial

NCT05032352 2022-11-14

PADMA

Insight Molecular Diagnostics

Terminated
55 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01063400 2012-02-14

Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors

University of Wisconsin, Madison

Terminated
6 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡